Stelis Biopharma Limited (Stelis or Company), a vertically integrated biopharma and vaccines Company and the biotech arm of Strides Pharma Science Limited, announced the appointment of Mark W. Womack (Mark) as the new Chief Executive Officer (CEO). Mark is also the Managing Director (MD) designate and shall be inducted to the Board later subject to necessary statutory […]
Tag: Stelis Biopharma
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Stelis Biopharma Pvt. Ltd., the biopharmaceutical division of Strides, a global pharmaceutical company headquartered in India, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 million people. The agreement […]
Stelis Biopharma (Stelis), a vertically integrated biopharmaceutical company, announced that it has successfully concluded its Series B and Series C fund raise for a cumulative amount of US$ 195 million. Post money valuation for Stelis will be pegged at ~US$ 350m, underpinning the significant growth potential of the business, the release said. With the current […]